Author:
Mousa Taghreed G.,Omar Hanan H.,Emad Rasha,Salama Mona I.,Omar Waleed,Fawzy Mohamed,Hassoba Howayda M.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference41 articles.
1. Yin C, Cai XB, Wang HJ et al (2018) Pathological significance and regulatory mechanism of lymphotoxin β receptor overexpression in T cells of patients with systemic lupus erythematosus. J Biomed Res 32(2):113–122
2. Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT, Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67(2):195–205
3. Naleway AL, Davis ME, Greenlee RT et al (2005) Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 14(10):862–866
4. Izmirly PM, Wan I, Sahl S et al (2017) The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: the Manhattan Lupus Surveillance Program. Arthritis Rheumatol (Hoboken, NJ) 69(10):2006–2017
5. Kanta H, Mohan C (2009) Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation. Genes Immun 10(5):390–396
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献